CN1104094A - Effervescent potassium permangan tablet - Google Patents
Effervescent potassium permangan tablet Download PDFInfo
- Publication number
- CN1104094A CN1104094A CN 94111834 CN94111834A CN1104094A CN 1104094 A CN1104094 A CN 1104094A CN 94111834 CN94111834 CN 94111834 CN 94111834 A CN94111834 A CN 94111834A CN 1104094 A CN1104094 A CN 1104094A
- Authority
- CN
- China
- Prior art keywords
- effervescent
- tablet
- potassium
- sterilization
- permangan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
The present invention relates to a disinfecting and sterilization drug for external application. It consists of potassium permanganate and effervescent agent. Its disinfecting and sterilization effect is reliable, and its dosage is accurate, so that it doesn't burn skin and mucosa, and can be quickly disintegrated and completely dissolved in water, and is convenient for using. It can be extensively used for preventing and curing diseases in various medical units, public places and families.
Description
The present invention relates to sterilization, sterilization medicine for external use.
In the prior art, potassium permanganate can be used for sterilization, sterilization, as skin, mucosa sterilization, gynecological's rinsing vulva.Also can be used for the sterilization of Bath utensil,, in addition, also can be used for the sterilization of ground and article surface etc. as washbasin, bathtub etc.Be loaded with potassium permanganate powder for two ones 519 pages at Pharmacopoeia of People's Republic of China (nineteen ninety version), its problem that mainly exists is that dissolving is slow, because potassium permanganate has stronger oxidisability, therefore dissolving incomplete particle adhesion can cause topical burn on skin, mucosa.Hospital also uses potassium permanganate powder, and it is bad to exist consumption to grasp equally, and dissolving is slowly dissolved incomplete deficiency.
The objective of the invention is to overcome above-mentioned weak point of the prior art and a kind of effervescent potassium permangan tablet is provided, its consumption is accurate, disintegrate is rapid, easy to use.
Prescription of the present invention is as follows: (per 1000):
Potassium permanganate 100~300g
Sodium bicarbonate 50g
Tartaric acid 50g
Carboxymethyl starch sodium 25g
Magnesium stearate 3g
The present invention compared with prior art has following advantage:
1, sterilization, bactericidal effect are reliable;
2, consumption is accurate, because this product is the divided dose dosage form, does not have excessive concentration or low excessively situation, therefore, does not cause burning of skin, mucosa;
3, disintegrate is rapid in water, and dissolving is conveniently used fully;
4, this product cooperates unit dose package, is fit to medical institutions, public place and family's prevention of disease and treatment widely.
Embodiment 1: a kind of effervescent potassium permangan tablet, and its prescription following (per 1000):
Potassium permanganate 100g
Sodium bicarbonate 50g
Tartaric acid 50g
Carboxymethyl starch sodium 25g
Magnesium stearate 3g
Behind above-mentioned prescription mix homogeneously, use φ 6mm punching press in blocks immediately, and pack immediately.
Embodiment 2, a kind of effervescent potassium permangan tablet, and its prescription following (per 1000):
Potassium permanganate 200g
Sodium bicarbonate 50g
Tartaric acid 50g
Carboxymethyl starch sodium 25g
Magnesium stearate 3g
Behind above-mentioned prescription mix homogeneously, use φ 7mm punching press in blocks immediately, and pack immediately.
Embodiment 3, a kind of effervescent potassium permangan tablet, and its prescription following (per 1000):
Potassium permanganate 300g
Sodium bicarbonate 50g
Tartaric acid 50g
Carboxymethyl starch sodium 25g
Magnesium stearate 3g
Behind above-mentioned prescription mix homogeneously, use φ 8mm punching press in blocks immediately, and pack immediately.
Claims (1)
1, a kind of effervescent potassium permangan tablet, its prescription are characterised in that (per 1000):
Potassium permanganate 100~300g
Sodium bicarbonate 50g
Tartaric acid 50g
Carboxymethyl starch sodium 25g
Magnesium stearate 3g.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 94111834 CN1104094A (en) | 1994-07-15 | 1994-07-15 | Effervescent potassium permangan tablet |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 94111834 CN1104094A (en) | 1994-07-15 | 1994-07-15 | Effervescent potassium permangan tablet |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1104094A true CN1104094A (en) | 1995-06-28 |
Family
ID=5035664
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 94111834 Pending CN1104094A (en) | 1994-07-15 | 1994-07-15 | Effervescent potassium permangan tablet |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1104094A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104170839A (en) * | 2014-06-11 | 2014-12-03 | 张卢军 | Broad-spectrum efficient disinfectant and preparation method thereof |
CN106038593A (en) * | 2016-07-28 | 2016-10-26 | 济南康福生制药有限公司 | Potassium permanganate tablets for external use and production process thereof |
-
1994
- 1994-07-15 CN CN 94111834 patent/CN1104094A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104170839A (en) * | 2014-06-11 | 2014-12-03 | 张卢军 | Broad-spectrum efficient disinfectant and preparation method thereof |
CN106038593A (en) * | 2016-07-28 | 2016-10-26 | 济南康福生制药有限公司 | Potassium permanganate tablets for external use and production process thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4750358B2 (en) | Strontium compounds for the treatment of pain in the subdermal soft tissue | |
KR100761051B1 (en) | Pharmaceutical compositions for the treatment of mucositis, stomatitis and Behcet's syndrome | |
MXPA04000764A (en) | Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide. | |
CN1627951A (en) | Compositions and method for prophylaxis and treatment of aphthous ulcers and herpes simplex lesions | |
RU95107881A (en) | Pharmaceutical composition for allergic disease treatment, method of antihistamine treatment, use of composition for medicinal preparation preparing | |
JPS62707B2 (en) | ||
US20060105057A1 (en) | Compositions using tetrasilver tetroxide and methods for management of skin conditions using same | |
CN1104094A (en) | Effervescent potassium permangan tablet | |
Platt et al. | Intraperitoneal antiseptics in experimental bacterial peritonitis | |
IL163091A (en) | Medical product and pharmaceutical composition comprising as active ingredients a thrombolytic agent and levosimendan or a pharmaceutically acceptable salt thereof and the use of same in the manufacture of medicament for reducing mortality of patients with acute myocardial infarction | |
RU2005488C1 (en) | Agent for connective tissue diseases treatment | |
CN1049572C (en) | Special sanitary paper towel for haemorrhoids and making method thereof | |
JP2003522109A (en) | Synergistic antibacterial dermatological and ophthalmic preparation containing chlorite and hydrogen peroxide | |
Carruthers | Prescribing antibiotics for impetigo | |
US20040022868A1 (en) | Compositions using tetrasilver tetroxide and methods for management of skin conditions using same | |
CN1055016C (en) | Powder for detoxifying and promoting tissue regeneration | |
CN1047521C (en) | Medicine for curing dermatophyte | |
CN1165306C (en) | Cold resisting compound medicinal composition | |
CN1062469C (en) | Vagina-cleaning effervescent agent and preparation process thereof | |
CN1229121C (en) | Ointment for moistening burn and scald and its making method | |
EP1195178B1 (en) | Immunotrophic preparation for treating adenotonsillary hypertrophy | |
Fornataro et al. | Viracept and irregular heartbeat warning | |
CN113244264A (en) | Novel protective agent for promoting healing of ulcer surface | |
Malov et al. | Relations of acid-base balance and gastric secretion of hydrogen carbonate ions in patients with peptic ulcer | |
CN1245071A (en) | Medicine for treating cervical erosion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C01 | Deemed withdrawal of patent application (patent law 1993) | ||
WD01 | Invention patent application deemed withdrawn after publication |